以下肢动脉血栓为首发表现的儿童系统性红斑狼疮合并抗磷脂综合征2例报告

doi:10.12372/jcp.2026.25e1528

临床儿科杂志 ›› 2026, Vol. 44 ›› Issue (6): 579-583.doi: 10.12372/jcp.2026.25e1528

以下肢动脉血栓为首发表现的儿童系统性红斑狼疮合并抗磷脂综合征2例报告

储卫红¹, 徐莉燕¹, 彭韶¹, 赖建铭²()

¹ 郑州大学第一附属医院儿科（河南郑州 450000）
² 首都医科大学附属首都儿童医学中心风湿免疫科（北京 100020）

收稿日期:2025-12-05 修回日期:2026-03-02 录用日期:2026-04-21 出版日期:2026-06-15 发布日期:2026-06-04
通讯作者: 赖建铭 E-mail:laijm99@sina.com
作者简介:第一联系人：作者贡献（Authors’ Contributions）
储卫红查阅文献、撰写论文；徐莉燕临床资料收集、整理；彭韶指导资料收集及论文撰写；赖建铭临床资料收集整理、指导论文撰写。

Lower extremity arterial thrombosis as first clinical manifestation in children's systemic lupus erythematosus complicated with antiphospholipid syndrome: a two-case report

CHU Weihong¹, XU Liyan¹, PENG Shao¹, LAI Jianming²()

¹ Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan, China
² Department of Rheumatology and Immunology, Capital Center for Children's Health Capital Medical University, Beijing 100020, China

Received:2025-12-05 Revised:2026-03-02 Accepted:2026-04-21 Published:2026-06-15 Online:2026-06-04
Contact: LAI Jianming E-mail:laijm99@sina.com

摘要/Abstract

摘要：

总结儿童系统性红斑狼疮合并抗磷脂综合征致下肢动脉血栓临床特点、治疗及预后，为临床医师提供诊治参考经验。收集系统性红斑狼疮合并抗磷脂综合征致下肢动脉血栓病例2例，比较分析其临床特点、治疗方案及预后的差异。患儿1给予糖皮质激素+环磷酰胺+贝利尤单抗+丙种球蛋白+羟氯喹+抗凝药物等治疗，最终仍出现坏疽，趾骨坏死脱落。随诊4年，血栓未再复发。患儿2给予糖皮质激素+利妥昔单抗+羟氯喹+抗凝药物+球囊扩张术+置管溶栓血栓抽吸术等治疗，随诊9个月，预后良好。儿童系统性红斑狼疮合并抗磷脂综合征可出现下肢动脉血栓，存在严重不良预后风险，应尽早诊断，积极治疗。

关键词: 下肢动脉血栓, 系统性红斑狼疮, 抗磷脂综合征, 儿童

Abstract:

To summarize clinical characteristics, treatment and prognosis of lower extremity arterial thrombosis caused by systemic lupus erythematosus (SLE) complicated with antiphospholipid syndrome (APS) in children, and to provide diagnostic and therapeutic experience for clinicians. Two cases of lower extremity arterial thrombosis caused by SLE complicated with APS were collected.The differences in clinical characteristics, treatment plans and prognosis were compared and analyzed between two cases. Patient 1 was treated with glucocorticoids, cyclophosphamide, belimumab, intravenous immunoglobulins, hydroxychloroquine and anticoagulation drug. However, gangrene still occurred, resulting in necrosis and eventual auto-amputation of toe bones. During a follow-up of 4 years, no thrombotic events recurred. Patient 2 was treated with glucocorticoids, rituximab, hydroxychloroquine, anticoagulation drug, balloon dilation, catheter-directed thrombolysis and thrombus aspiration. The patient had a good prognosis after 9 months of follow-up. Children with SLE complicated by APS may develop lower extremity arterial thrombosis, which carries a risk of serious adverse outcomes. Early diagnosis and active treatment are crucial.

Key words: lower extremity arterial thrombosis, systemic lupus erythematosus, antiphospholipid syndrome, child

中图分类号:

储卫红, 徐莉燕, 彭韶, 赖建铭. 以下肢动脉血栓为首发表现的儿童系统性红斑狼疮合并抗磷脂综合征2例报告[J]. 临床儿科杂志, 2026, 44(6): 579-583.

CHU Weihong, XU Liyan, PENG Shao, LAI Jianming. Lower extremity arterial thrombosis as first clinical manifestation in children's systemic lupus erythematosus complicated with antiphospholipid syndrome: a two-case report[J]. Journal of Clinical Pediatrics, 2026, 44(6): 579-583.

图/表 7

图1

图2

图3

图4

图5

图6

图7

参考文献 15

[1]	Nagy N, Papp G, Gáspár-Kiss E, et al. Changes in clinical manifestations and course of systemic lupus erythematosus and secondary antiphospholipid syndrome over three decades[J]. Biomedicines, 2023, 11(4): 1218.
[2]	Tanariyakul M, Nebrajas K, Saowapa S, et al. Extensive thrombosis in catastrophic antiphospholipid syndrome in a newly diagnosed systemic lupus erythematosus: a case report[J]. Cureus, 2024, 16(5): e59542.
[3]	Nakashima M, Kobayashi M. Preceding antiphospholipid syndrome before the onset of systemic lupus erythematosus presenting with iliocaval deep vein thrombosis: a case report and literature review[J]. Ann Vasc Dis, 2024, 17(4): 409-412.
[4]	Mushtaq MZ, Ahsan Ali S, Sattar Z, et al. A retrospective review of antiphospholipid syndrome from a South Asian country[J]. Arch Rheumatol, 2021, 37(1): 31-39.
[5]	Moorani KN, Kashif S. Antiphospholipid syndrome presenting as isolated renal vein thrombosis: a case report and review of the literature[J]. J Med Case Rep, 2025, 19(1): 123.
[6]	Lingjuan Liu, Liqun Liu, Lu Zhang, et al. Case report: a case of recurrent thrombosis in pediatric antiphospholipid syndrome associated with pediatric onset systemic lupus[J]. Front Pediatr, 2023, 10: 1004053.
[7]	Chiang YJ, Hu YC, Chiang BL. A significant improvement of thromboses treated by a new oral anticoagulant in an 11-year-old girl with systemic lupus erythematosus associated antiphospholipid syndrome: a case report[J]. Lupus, 2021, 30(8): 1338-1341.
[8]	Cheng C, Cheng GY, Denas G, et al. Arterial thrombosis in antiphospholipid syndrome (APS): clinical approach and treatment. a systematic review[J]. Blood Rev, 2021, 48: 100788.
[9]	Rup AR, Dash AK, Behera JR, et al. Antiphospholipid antibody syndrome in childhood systemic lupus erythematous with a unique presentation: a case report[J]. Cureus, 2022, 14(7): e27205.
[10]	Radin M, Cecchi I, Arbrile M, et al. Pediatric presentation of antiphospholipid syndrome: a review of recent literature with estimation of local prevalence[J]. Semin Thromb Hemost, 2024, 50(2): 182-187.
[11]	Feng Y, Chen N, Dai B, et al. Case Report: In situ pulmonary artery thrombosis in a 12-year-old girl classified as systemic lupus erythematosus[J]. Front Pediatr, 2024, 12: 1341188.
[12]	Ranjan R, Mehta S, Saxena KN. Unveiling uncommon manifestations in a pediatric patient with systemic lupus erythematosus: a case report[J]. Cureus, 2021, 13(12): e20418.
[13]	Alzughayyar TZ, Zalloum JS, Elqadi MN, et al. Systemic lupus erythematosus with multiple autoimmune disease presented with extensive peripheral gangrene[J]. Case Rep Rheumatol, 2020, 2020: 8278275.
[14]	Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus[J]. Arthritis Rheumatol, 2019, 71(9): 1400-1412.
[15]	Barbhaiya M, Zuily S, Naden R, et al. The 2023 ACR/EULAR antiphospholipid syndrome classification criteria[J]. Arthritis Rheumatol, 2023, 75(10): 1687-1702.

以下肢动脉血栓为首发表现的儿童系统性红斑狼疮合并抗磷脂综合征2例报告

Lower extremity arterial thrombosis as first clinical manifestation in children's systemic lupus erythematosus complicated with antiphospholipid syndrome: a two-case report

RichHTML

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

图/表 7

参考文献 15

相关文章 15

Metrics

本文评价

推荐阅读 0

[1]	胡燕, 杨凡, 梁爱民, 毛萌. 生长减缓儿童的识别与管理：第十三届国际营养与生长会议要点解读[J]. 临床儿科杂志, 2026, 44(6): 485-488.
[2]	刘子尧, 王聪颖, 王宏茂, 张明明, 许瑛杰, 赖建铭, 牛文全, 李晓惠. 伴关节症状川崎病与川崎病样症状起病全身型幼年特发性关节炎的早期鉴别：一项单中心回顾性研究[J]. 临床儿科杂志, 2026, 44(6): 489-498.
[3]	李健, 李涛, 何璐璐, 吴磊, 胡天骄, 黄怡璇, 林新蓉, 沈启阳, 潘思蕊, 谢男, 周建峰, 周春雷, 周莉. 儿童恶性横纹肌样瘤50例回顾性分析：临床特征、治疗反应及预后影响因素[J]. 临床儿科杂志, 2026, 44(6): 499-507.
[4]	李艳华, 张欢欢, 杨静薇, 廖雪莲, 邵静波, 焦瑒瑒, 张婷, 黄灿, 蒋莎义. 儿童头颈部横纹肌肉瘤生存预后及相关危险因素分析[J]. 临床儿科杂志, 2026, 44(6): 518-523.
[5]	石永媛, 杨丽娟, 雷文婷, 熊玉蓉, 潘书静, 李跃林, 张佳丽, 田茂强. 儿童自身免疫性脑炎合并运动障碍的临床特征及预后分析：一项单中心回顾性研究[J]. 临床儿科杂志, 2026, 44(6): 532-539.
[6]	顾信佳, 郑智慧, 梅伶俐, 郑金鑫, 刘太祥, 诸纪华. 1990—2023年中国儿童和青少年泌尿系统疾病负担研究[J]. 临床儿科杂志, 2026, 44(6): 546-555.
[7]	陈旭梅, 艾比白·艾尔肯, 岳雪艳, 茹凉, 张莉. 哮喘患儿家长心理弹性与应对方式的潜在剖面分析及影响因素研究[J]. 临床儿科杂志, 2026, 44(6): 556-563.
[8]	罗自豪, 李少军, 任佩珍, 王艳红, 耿刚. 儿童肺炎并发塑型性支气管炎临床特征分析及风险预测模型建立与验证[J]. 临床儿科杂志, 2026, 44(6): 564-572.
[9]	陈刘王, 刘盼, 席荣娟, 张先霞, 张毅, 韦性娇, 苏敏, 杨永红, 付扬喜. 甲基丙二酸血症合并同型半胱氨酸血症致儿童脊髓亚急性联合变性1例报告[J]. 临床儿科杂志, 2026, 44(6): 584-588.
[10]	施杰娜, 张俊琦, 沈珑慧. 艾沙康唑在儿童毛霉病治疗中的研究进展与临床思考[J]. 临床儿科杂志, 2026, 44(6): 589-594.
[11]	中国妇幼保健协会儿童变态反应专业委员会中华医学会儿科学分会皮肤性病学组《临床儿科杂志》编辑委员会. 儿童特应性皮炎非药物干预管理专家共识[J]. 临床儿科杂志, 2026, 44(5): 381-393.
[12]	赵欣荣, 徐子刚. CARD14变异相关皮肤病的分子机制与诊治进展[J]. 临床儿科杂志, 2026, 44(5): 399-404.
[13]	郝延召, 李弯月, 李建国, 窦进法, 禹卉千, 王建波. 度普利尤单抗治疗儿童中重度特应性皮炎短期疗效与复发风险: 一项单中心回顾性研究[J]. 临床儿科杂志, 2026, 44(5): 412-417.
[14]	董瑛, 曹婷婷, 吴健平, 张莉, 葛宏松. 儿童和青少年掌跖黑素细胞痣的皮肤镜下特征分析[J]. 临床儿科杂志, 2026, 44(5): 418-423.
[15]	黄书越, 程明, 王稀欧, 宋弋, 杜牧, 宋福英, 曹冰燕. 儿童果糖-1，6-二磷酸酶缺乏症4例临床特征与文献复习[J]. 临床儿科杂志, 2026, 44(5): 438-444.